Sponsor or institution
Clinical trials and research at National Cancer Institute, Naples
As of November 12, 2026, Find a Trial lists 29 clinical trials run by National Cancer Institute, Naples that are recruiting, at sites in 2 countries (most in Italy (29), Spain (1)). By phase: Phase 2 (9), Phase 3 (2), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 29Clinical trials
- 2Countries
Newest trials
All recruiting trials (29)
-
Single microdose [68Ga]Ga-R54 PET scan to image CXCR4 in advanced solid tumors and multiple myeloma
We will try a single microdose of the PET tracer [68Ga]Ga-R54 to see if it binds CXCR4 in people with advanced solid tumors or multiple myeloma.
-
Financial burden in early-stage breast cancer
This project will see if people with early-stage breast cancer experience meaningful financial hardship during the first year of treatment using the PROFFIT questionnaire.
-
Relugolix with SBRT for erectile function recovery after prostate cancer therapy
This study tests whether men with advanced prostate cancer who stop hormone therapy and receive targeted SBRT can regain erectile function within six months.
-
Pembrolizumab plus lenvatinib for vulvar cancer (MITO VULVA-01)
This trial will test whether combining pembrolizumab with lenvatinib helps people with advanced, recurrent, or unresectable vulvar cancer.
-
Neoadjuvant dostarlimab for locally advanced dMMR/MSI‑H rectal cancer in routine practice
This project will try neoadjuvant dostarlimab in adults with dMMR/MSI‑H stage II–III rectal cancer to see how well it works and how safe it is in real-world clinical care.
-
Second-line regorafenib for advanced RAS-mutant colorectal cancer
This trial will test whether regorafenib given as a less-intensive, personalized second-line option can preserve quality of life and extend survival for people with RAS‑mutant metastatic colorectal cancer who had a long first-line benefit or have only one metastatic site.
-
Adding simvastatin to nivolumab and oxaliplatin-based chemotherapy for ARID1A‑mutated advanced gastroesophageal cancer
This trial will test whether adding daily simvastatin to nivolumab plus oxaliplatin-based chemotherapy helps people with HER2-negative, ARID1A-mutated advanced gastroesophageal cancer stay progression-free longer.
-
Single‑incision da Vinci SP robotic surgical staging for endometrial cancer
This study will try using the da Vinci SP single‑port robotic system to perform surgical staging in adults with endometrial cancer to see how it works and how patients recover.
-
Discovering tumor antigens for innovative cancer treatments in liver cancer
This study is trying to find new cancer treatments for liver cancer by looking at the gut bacteria in patients and seeing how it compares to healthy people and those with other cancers.
-
Biomarker analysis for patients with advanced head and neck cancer
This study is testing if certain biomarkers in biopsy samples can help predict how well patients with advanced head and neck cancer will respond to their treatment.
-
Creating a network for precision oncology in central-southern Italy
This study is trying to create a network of labs in central-southern Italy to better understand cancer by improving testing methods and sharing information about tumors to help personalize treatment for patients.
-
Using metabolomic profiling to screen for endometrial cancer
This study is testing a new way to use blood samples to see if certain markers can help identify endometrial cancer in women compared to other types of growths and cancers.
-
Tele-consultation to improve colonoscopy quality and reduce anxiety
This study tests if a tele-consultation with nurses can help people getting a colonoscopy feel less anxious and better prepared for the procedure compared to standard care.
-
Exploring the link between colon cancer and chronic kidney disease
This study is trying to see how chronic kidney disease affects the growth of early-stage colon cancer in patients who are having surgery.
-
Advanced cancer diagnosis using multi-omic profiling
This study is testing a new way to improve cancer diagnosis by using a mix of biological samples and medical images to help doctors choose the best treatments for patients in Italy.
-
Adding valproic acid to panitumumab and irinotecan for metastatic colorectal cancer rechallenge
This trial tests whether giving oral valproic acid along with panitumumab and irinotecan helps people with RAS/BRAF wild-type metastatic colorectal cancer who are being rechallenged with anti‑EGFR therapy.
-
Comparing intermittent and continuous treatment for metastatic colorectal cancer
This study is testing whether taking a cancer treatment in breaks instead of continuously can work just as well for people with a specific type of metastatic colorectal cancer.
-
Neoadjuvant chemotherapy and immunotherapy for advanced cholangiocarcinoma
This study is testing a combination of chemotherapy and immunotherapy before surgery to see if it can help people with advanced cholangiocarcinoma have fewer cancer recurrences within a year after their operation.
-
Collecting cancer patient data in the Campania region
This study is gathering information from cancer patients in the Campania region to see how their treatment and care can be improved.
-
Understanding the mechanisms behind squamous cell carcinomas
This study is trying to learn more about squamous cell carcinoma by looking at samples from patients to see how certain markers and cells affect the disease and its treatment.
-
Evaluating financial distress in ovarian cancer treatment
This study is trying to see how different treatment plans for ovarian cancer affect the financial stress that patients experience over time.
-
Combining Valproic Acid and Simvastatin with Gemcitabine and Nab-paclitaxel for Metastatic Pancreatic Cancer
This study is testing if adding valproic acid and simvastatin to standard chemotherapy can help people with untreated metastatic pancreatic cancer live longer without their disease getting worse.
-
Exploring selenoproteins in breast cancer prognosis and treatment.
This study is testing whether selenoproteins can help predict outcomes and guide treatment for people with triple-negative breast cancer.
-
Observational study on rare gynecological cancers
This study is trying to learn more about rare gynecological cancers to improve treatment and care for patients facing these conditions.
-
Comparing Olaparib to Platinum Chemotherapy for Recurrent Ovarian Cancer After Surgery
This study is testing if a new drug called olaparib can help women with recurrent ovarian cancer feel better after surgery compared to the usual platinum chemotherapy.
-
Evaluating Cabozantinib and Temozolomide for Lung and GEP Neuroendocrine Tumors
This study is testing if combining two medications, Cabozantinib and Temozolomide, can help people with advanced lung and gastroenteropancreatic neuroendocrine tumors who haven't responded to other treatments.
-
Evaluating the effects of radiation therapy on colorectal cancer patients with lung-limited metastases
This study is testing if a special type of radiation therapy can help people with colorectal cancer that has spread to their lungs by looking at changes in their tumor DNA and genetics before and after treatment.
-
Assessing cancer pain using machine learning and telemedicine
This study is testing a new way to help cancer patients manage their pain better by using technology and support from healthcare teams while they stay at home.
-
Treatment for Stage IV Colorectal Cancer with Folfiri and Cetuximab
This study is testing if a combination of Folfiri and Cetuximab can help people with stage IV colorectal cancer who have a specific gene type feel better and improve their treatment results.
Quick answers
How many clinical trials run by National Cancer Institute, Naples are recruiting right now?
29, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (29 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 9, Phase 3: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.